Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.69 Billion USD | 30.02% |
| 2022 | 1.3 Billion USD | 18.79% |
| 2021 | 1.09 Billion USD | 21.49% |
| 2020 | 904.4 Million USD | 22.51% |
| 2019 | 738.2 Million USD | 30.93% |
| 2018 | 563.82 Million USD | 21.57% |
| 2017 | 463.76 Million USD | 26.37% |
| 2016 | 366.98 Million USD | 39.07% |
| 2015 | 263.89 Million USD | -8.6% |
| 2014 | 288.72 Million USD | 16.85% |
| 2013 | 247.08 Million USD | 16.9% |
| 2012 | 211.36 Million USD | 38.83% |
| 2011 | 152.25 Million USD | 57.02% |
| 2010 | 96.96 Million USD | 46.85% |
| 2009 | 66.03 Million USD | 83.12% |
| 2008 | 36.05 Million USD | 169.66% |
| 2007 | 13.37 Million USD | 265.06% |
| 2006 | 3.66 Million USD | 7226.0% |
| 2005 | 50 Thousand USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 441.7 Million USD | -13.36% |
| 2024 Q2 | 488.5 Million USD | 10.6% |
| 2023 FY | 1.69 Billion USD | 30.02% |
| 2023 Q4 | 509.8 Million USD | 17.82% |
| 2023 Q3 | 432.7 Million USD | 9.13% |
| 2023 Q1 | 358.1 Million USD | -3.14% |
| 2023 Q2 | 396.5 Million USD | 10.72% |
| 2022 Q1 | 295.4 Million USD | -4.0% |
| 2022 Q2 | 299.4 Million USD | 1.35% |
| 2022 Q3 | 340.8 Million USD | 13.83% |
| 2022 Q4 | 369.7 Million USD | 8.48% |
| 2022 FY | 1.3 Billion USD | 18.79% |
| 2021 Q2 | 263.2 Million USD | 4.32% |
| 2021 FY | 1.09 Billion USD | 21.49% |
| 2021 Q4 | 307.7 Million USD | 11.65% |
| 2021 Q1 | 252.3 Million USD | 2.52% |
| 2021 Q3 | 275.6 Million USD | 4.71% |
| 2020 Q3 | 234 Million USD | 3.4% |
| 2020 Q2 | 226.3 Million USD | 14.29% |
| 2020 Q1 | 198 Million USD | -5.44% |
| 2020 FY | 904.4 Million USD | 22.51% |
| 2020 Q4 | 246.1 Million USD | 5.17% |
| 2019 FY | 738.2 Million USD | 30.93% |
| 2019 Q1 | 159.55 Million USD | -3.25% |
| 2019 Q2 | 177.13 Million USD | 11.02% |
| 2019 Q3 | 192.11 Million USD | 8.46% |
| 2019 Q4 | 209.4 Million USD | 9.0% |
| 2018 Q1 | 123.57 Million USD | -5.32% |
| 2018 Q2 | 124.26 Million USD | 0.55% |
| 2018 Q3 | 151.07 Million USD | 21.58% |
| 2018 FY | 563.82 Million USD | 21.57% |
| 2018 Q4 | 164.9 Million USD | 9.15% |
| 2017 Q1 | 101.71 Million USD | -1.8% |
| 2017 FY | 463.76 Million USD | 26.37% |
| 2017 Q4 | 130.52 Million USD | 7.18% |
| 2017 Q3 | 121.77 Million USD | 10.95% |
| 2017 Q2 | 109.75 Million USD | 7.91% |
| 2016 Q2 | 87.33 Million USD | 7.53% |
| 2016 Q1 | 81.21 Million USD | -18.88% |
| 2016 Q4 | 103.57 Million USD | 9.17% |
| 2016 FY | 366.98 Million USD | 39.07% |
| 2016 Q3 | 94.87 Million USD | 8.64% |
| 2015 Q3 | 87.3 Million USD | 15.5% |
| 2015 Q1 | 61.21 Million USD | -15.64% |
| 2015 FY | 263.89 Million USD | -8.6% |
| 2015 Q4 | 100.11 Million USD | 14.68% |
| 2015 Q2 | 75.58 Million USD | 23.48% |
| 2014 FY | 288.72 Million USD | 16.85% |
| 2014 Q4 | 72.56 Million USD | -3.23% |
| 2014 Q1 | 69.16 Million USD | 0.92% |
| 2014 Q2 | 72.01 Million USD | 4.12% |
| 2014 Q3 | 74.98 Million USD | 4.13% |
| 2013 Q2 | 60.09 Million USD | 4.77% |
| 2013 FY | 247.08 Million USD | 16.9% |
| 2013 Q4 | 68.53 Million USD | 12.16% |
| 2013 Q3 | 61.1 Million USD | 1.68% |
| 2013 Q1 | 57.35 Million USD | -0.82% |
| 2012 Q4 | 57.82 Million USD | 5.62% |
| 2012 Q1 | 47.75 Million USD | 1.19% |
| 2012 Q3 | 54.75 Million USD | 7.28% |
| 2012 Q2 | 51.03 Million USD | 6.87% |
| 2012 FY | 211.36 Million USD | 38.83% |
| 2011 Q2 | 32.21 Million USD | 13.99% |
| 2011 Q4 | 47.19 Million USD | 5.83% |
| 2011 Q3 | 44.59 Million USD | 38.44% |
| 2011 Q1 | 28.25 Million USD | 1.77% |
| 2011 FY | 152.25 Million USD | 57.02% |
| 2010 Q1 | 20.8 Million USD | 2.95% |
| 2010 Q3 | 25.45 Million USD | 10.98% |
| 2010 Q2 | 22.93 Million USD | 10.24% |
| 2010 Q4 | 27.76 Million USD | 9.08% |
| 2010 FY | 96.96 Million USD | 46.85% |
| 2009 Q4 | 20.21 Million USD | 7.88% |
| 2009 FY | 66.03 Million USD | 83.12% |
| 2009 Q3 | 18.73 Million USD | 28.17% |
| 2009 Q2 | 14.61 Million USD | 17.23% |
| 2009 Q1 | 12.46 Million USD | 5.13% |
| 2008 Q4 | 11.86 Million USD | 17.32% |
| 2008 FY | 36.05 Million USD | 169.66% |
| 2008 Q1 | 6.67 Million USD | 52.97% |
| 2008 Q2 | 7.41 Million USD | 11.18% |
| 2008 Q3 | 10.11 Million USD | 36.31% |
| 2007 Q1 | 2 Million USD | 22.36% |
| 2007 Q4 | 4.36 Million USD | 15.04% |
| 2007 FY | 13.37 Million USD | 265.06% |
| 2007 Q3 | 3.79 Million USD | 18.03% |
| 2007 Q2 | 3.21 Million USD | 59.96% |
| 2006 FY | 3.66 Million USD | 7226.0% |
| 2006 Q2 | 674 Thousand USD | 0.0% |
| 2006 Q1 | 674 Thousand USD | 0.0% |
| 2006 Q3 | 674 Thousand USD | 0.0% |
| 2006 Q4 | 1.64 Million USD | 143.47% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | 50 Thousand USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -13973.306% |
| BrainsWay Ltd. | 31.78 Million USD | -5239.311% |
| Cerus Corporation | 156.36 Million USD | -985.331% |
| Envoy Medical, Inc. | 316 Thousand USD | -536956.962% |
| electroCore, Inc. | 16.03 Million USD | -10487.024% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -263424.845% |
| IceCure Medical Ltd | 3.22 Million USD | -52458.068% |
| Inogen, Inc. | 315.66 Million USD | -437.635% |
| OrthoPediatrics Corp. | 148.73 Million USD | -1041.046% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -69797.035% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -464860.178% |
| MaxCyte, Inc. | 41.28 Million USD | -4010.395% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -86821.961% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1532297.876% |
| Orthofix Medical Inc. | 746.64 Million USD | -127.298% |
| PAVmed Inc | 2.45 Million USD | -69112.887% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -7436.303% |
| RxSight, Inc. | 89.07 Million USD | -1805.206% |
| Sight Sciences, Inc. | 81.05 Million USD | -1993.738% |
| SI-BONE, Inc. | 138.88 Million USD | -1121.937% |
| TELA Bio, Inc. | 58.45 Million USD | -2803.358% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -806.968% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -12196.935% |
| Acutus Medical, Inc. | 7.16 Million USD | -23589.28% |
| Talis Biomedical Corporation | 412 Thousand USD | -411817.476% |
| Spectral AI, Inc. | 18.05 Million USD | -9299.092% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -17033.771% |
| CVRx, Inc. | 39.29 Million USD | -4218.87% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -175092.473% |
| Bioventus Inc. | 512.34 Million USD | -231.242% |
| Venus Concept Inc. | 76.35 Million USD | -2122.673% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -9068.062% |
| LivaNova PLC | 1.15 Billion USD | -47.12% |
| 908 Devices Inc. | 50.22 Million USD | -3278.725% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -251.904% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -2202667.25% |
| NeuroPace, Inc. | 65.42 Million USD | -2494.121% |
| LENSAR, Inc. | 42.16 Million USD | -3924.998% |
| Apyx Medical Corporation | 52.34 Million USD | -3141.896% |
| Cutera, Inc. | 212.36 Million USD | -699.128% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -4987.535% |
| BioSig Technologies, Inc. | 18 Thousand USD | -9428233.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -918.289% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -6984.534% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | -10.089% |
| Axonics, Inc. | 366.37 Million USD | -363.209% |
| Outset Medical, Inc. | 130.37 Million USD | -1201.697% |
| IRIDEX Corporation | 51.86 Million USD | -3171.897% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -1146.118% |
| IRadimed Corporation | 65.56 Million USD | -2488.53% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -144211.224% |
| INVO Bioscience, Inc. | 3.02 Million USD | -56084.667% |
| Telesis Bio, Inc. | 27.5 Million USD | -6069.254% |
| Viemed Healthcare, Inc. | 183 Million USD | -827.337% |
| Varex Imaging Corporation | 811 Million USD | -109.26% |
| Quipt Home Medical Corp. | 221.74 Million USD | -665.349% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -2371.205% |
| Dynatronics Corporation | 32.53 Million USD | -5116.395% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -19456.349% |
| Semler Scientific, Inc. | 68.18 Million USD | -2389.0% |
| InMode Ltd. | 492.04 Million USD | -244.905% |
| Bruker Corporation | 2.96 Billion USD | 42.753% |
| Cytosorbents Corporation | 36.34 Million USD | -4568.856% |
| DexCom, Inc. | 3.62 Billion USD | 53.149% |
| Align Technology, Inc. | 3.86 Billion USD | 56.059% |
| Viveve Medical, Inc. | 6.42 Million USD | -26309.897% |
| ZimVie Inc. | 457.43 Million USD | -271.005% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -779.258% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1532297.876% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | -126.971% |
| Profound Medical Corp. | 7.33 Million USD | -23049.572% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -1246.071% |
| iCAD, Inc. | 17.31 Million USD | -9699.63% |
| Nuwellis, Inc. | 8.86 Million USD | -19045.984% |
| Biotricity, Inc. | 12.06 Million USD | -13968.237% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -244.462% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -27250.524% |
| PAVmed Inc. | 2.45 Million USD | -69112.887% |
| BIOLASE, Inc. | 49.16 Million USD | -3351.916% |
| Beyond Air, Inc. | 1.15 Million USD | -146327.955% |
| FONAR Corporation | 102.88 Million USD | -1549.526% |
| AxoGen, Inc. | 159.01 Million USD | -967.278% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -518.425% |
| Inari Medical, Inc. | 493.63 Million USD | -243.799% |
| UFP Technologies, Inc. | 400.07 Million USD | -324.199% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -9124093.548% |
| Tenon Medical, Inc. | 2.92 Million USD | -57861.066% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -24813.249% |
| AdaptHealth Corp. | 3.2 Billion USD | 46.969% |
| Sintx Technologies, Inc. | 2.62 Million USD | -64502.208% |
| NanoVibronix, Inc. | 2.28 Million USD | -74236.399% |
| Quanterix Corporation | 122.36 Million USD | -1286.882% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -6853.903% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -746.345% |
| TransMedics Group, Inc. | 241.62 Million USD | -602.375% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -12149.892% |
| NeuroMetrix, Inc. | 5.9 Million USD | -28657.461% |
| Hyperfine, Inc. | 11.03 Million USD | -15283.43% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -927.605% |
| Biomerica, Inc. | 5.41 Million USD | -31240.72% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -3256.539% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -858.088% |